Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 21857974)

1.

The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment.

Lee BH, Kim YK.

Psychiatry Investig. 2010 Dec;7(4):231-5. doi: 10.4306/pi.2010.7.4.231. Epub 2010 Nov 23.

2.

Determinants of serum brain-derived neurotrophic factor.

Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, Elzinga BM, Voshaar RC.

Psychoneuroendocrinology. 2011 Feb;36(2):228-39. doi: 10.1016/j.psyneuen.2010.07.013. Epub 2010 Aug 10.

PMID:
20702043
3.

Blood BDNF concentrations reflect brain-tissue BDNF levels across species.

Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S.

Int J Neuropsychopharmacol. 2011 Apr;14(3):347-53. doi: 10.1017/S1461145710000738. Epub 2010 Jul 7.

PMID:
20604989
4.

Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data.

Marullo M, Zuccato C, Mariotti C, Lahiri N, Tabrizi SJ, Di Donato S, Cattaneo E.

Genome Biol. 2010 Jan 28;11(1):R9. doi: 10.1186/gb-2010-11-1-r9.

5.

Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.

Castrén E, Rantamäki T.

CNS Drugs. 2010 Jan;24(1):1-7. doi: 10.2165/11530010-000000000-00000. Review.

PMID:
20030415
6.

Gene expression changes in blood as a putative biomarker for Huntington's disease.

Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B.

Mov Disord. 2009 Nov 15;24(15):2277-81. doi: 10.1002/mds.22477.

PMID:
19844910
7.

Brain-derived neurotrophic factor in neurodegenerative diseases.

Zuccato C, Cattaneo E.

Nat Rev Neurol. 2009 Jun;5(6):311-22. doi: 10.1038/nrneurol.2009.54. Review.

PMID:
19498435
8.

Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides.

Yi J, Liu Z, Craft D, O'Mullan P, Ju G, Gelfand CA.

J Proteome Res. 2008 Dec;7(12):5112-8. doi: 10.1021/pr800396c.

PMID:
19367699
9.

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Squitieri F, Orobello S, Cannella M, Martino T, Romanelli P, Giovacchini G, Frati L, Mansi L, Ciarmiello A.

Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1113-20. doi: 10.1007/s00259-009-1103-3. Epub 2009 Mar 11.

PMID:
19280185
10.

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P.

Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1050-62. doi: 10.1002/ajmg.b.30930.

PMID:
19219856
11.

Thrombin induces broad spectrum proteolysis in human serum samples.

O'Mullan P, Craft D, Yi J, Gelfand CA.

Clin Chem Lab Med. 2009;47(6):685-93. doi: 10.1515/CCLM.2009.003.

PMID:
19099528
12.

CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.

Apostol BL, Simmons DA, Zuccato C, Illes K, Pallos J, Casale M, Conforti P, Ramos C, Roarke M, Kathuria S, Cattaneo E, Marsh JL, Thompson LM.

Mol Cell Neurosci. 2008 Sep;39(1):8-20. doi: 10.1016/j.mcn.2008.04.007. Epub 2008 Apr 24.

PMID:
18602275
13.

Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.

Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E.

Mol Cell Neurosci. 2008 Sep;39(1):1-7. doi: 10.1016/j.mcn.2008.04.012. Epub 2008 May 10.

PMID:
18571429
14.

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H, Ueda N, Nakamura J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):679-85. Epub 2007 Nov 17.

PMID:
18160197
15.

Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease.

Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E.

Brain Pathol. 2008 Apr;18(2):225-38. Epub 2007 Dec 17.

PMID:
18093249
16.

Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects.

Tang SW, Chu E, Hui T, Helmeste D, Law C.

Neurosci Lett. 2008 Jan 24;431(1):62-5. Epub 2007 Nov 17.

PMID:
18068900
17.

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, Régulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R.

Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14424-9. Epub 2007 Aug 27.

18.

Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters.

Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T.

Genomics. 2007 Sep;90(3):397-406. Epub 2007 Jul 12.

19.

Neurotrophins and schizophrenia.

Buckley PF, Mahadik S, Pillai A, Terry A Jr.

Schizophr Res. 2007 Aug;94(1-3):1-11. Epub 2007 May 23. Review.

PMID:
17524622
20.

Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data.

Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM.

Brain Res Bull. 2007 Jun 15;73(1-3):143-9. Epub 2007 Apr 9.

PMID:
17499648
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk